Skip to content

Alastair J. Flint

2 papers in the library · publishing 2025-2026

Papers

Sort Most recent Most cited

Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression

JAMA Psychiatry September 2, 2026 Diana Orsini, Sara Di Luch, George Tomlinson et al.

Importance Antidepressant efficacy of intravenous (IV) ketamine has been demonstrated in major depressive disorder; however, the efficacy and safety of ketamine for bipolar depression remain largely unknown, with limited data available in this specific population. Objective To evaluate the efficacy, safety, and tolerability of adjunctive IV ketamine compared with midazolam for...

Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study

Alzheimer s & Dementia December 1, 2025 Danielle Bukovsky, Aron Amaev, Jianmeng Song et al.

Abstract Background Amnestic mild cognitive impairment (aMCI) is characterized by synaptic loss and cognitive decline and is considered a precursor to Alzheimer’s Disease. Currently, there are no effective treatments for aMCI, and available treatments (i.e., cholinesterase inhibitors) do not appear to improve cognitive or functional outcomes. Psychedelics, including psilocybin, have regained...

DOI: 10.1002/alz70859_101101 (opens in new tab) Psilocybin Tolerability Memantine Adverse effect +11